Latest News

Pq Bypass

PQ Bypass Announces $60M Financing

8th January 2019

PQ Bypass Announces $60 Million Financing to Advance New Therapeutic Approach to Peripheral Arterial Disease. Funds Will Support Pivotal Trial of Novel DETOUR System Designed for Patients with Tough to Treat Long Blockages in Leg Arteries. January 08, 2019. Ireland […]

Read More
Atlantic Innovo News

Atlantic Therapeutics Raise €28M in Series B Funding

7th January 2019

Seroba portfolio company, Atlantic Therapeutics, has raised €28 million following FDA approval for its INNOVO® therapy device to treat incontinence. This funding facilitates the company’s next growth phase, including geographic expansion to US and other markets, new product launches and […]

Read More
Quanta News

Quanta Appoints New Chief Medical Officer

4th January 2019

Alcester, UK, 4 Jan 2019: Seroba portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions for clinic and home settings, today announced the Company has appointed Dr Paul Komenda as CMO. […]

Read More
Veryan News

Otsuka Medical Devices Acquires Veryan

14th December 2018

Dublin, Ireland, 14 December, 2018.  Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), a 100% subsidiary of Otsuka Holdings Co., Ltd., and Veryan Medical Ltd. (“Veryan”) have announced the completion of the acquisition of Veryan by Otsuka Medical Devices through […]

Read More
Atlantic Innovo News

Atlantic Therapeutics Secures FDA Approval

13th November 2018

FDA Grants DeNovo Clearance to Atlantic Therapeutics for INNOVO® Therapy Device to Treat Stress Urinary Incontinence. Galway, Ireland. 13 November 2018. Seroba’s portfolio company, Atlantic Therapeutics, a global manufacturer of innovative, garment-based pelvic floor muscle strengthening and nerve stimulation products, […]

Read More
Veryan Premarket Approval

Veryan Receives PreMarket Approval

5th October 2018

Horsham, UK. 05 October 2018: Seroba Investee, Veryan Medical Ltd, today announced that the Company has received Premarket Approval (PMA) for the BioMimics 3D Vascular Stent System from the U.S. Food & Drug Administration (FDA).  The device is approved for […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19

Scroll to Top